We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly and BI Get FDA Approval for Combo Type 2 Diabetes Drug
Lilly and BI Get FDA Approval for Combo Type 2 Diabetes Drug
The FDA has green-lighted Eli Lilly and Boehringer Ingelheim’s combination treatment Glyxambi as an adjunct to diet and exercise for adults with type 2 diabetes.